Inflammation and airway function in the lung periphery of patients with stable asthma

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 3, 2010, Pages 611-616

  Verbanck, Sylvia ^a   Schuermans, Daniel ^a   Vincken, Walter ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUTICASONE; NITRIC OXIDE;

ADULT; AIR CONDUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXHALATION; EXPIRATORY FLOW RATE; FEMALE; HUMAN; LUNG ALVEOLUS; LUNG FUNCTION; LUNG VENTILATION; MALE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW;

ADULT; ASTHMA; BREATH TESTS; EXHALATION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY ALVEOLI; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 77649271741     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.053     Document Type: Article

References (36)

1. Malinovschi A., Janson C., Holm L., Nordvall L., and Alving K. Basal and induced NO formation in the pharyngo-oral tract influences estimates of alveolar NO levels. J Appl Physiol 106 (2009) 513-519
2. Verbanck S., Kerckx Y., Schuermans D., Vincken W., Paiva M., and Van Muylem A. Effect of airways constriction on exhaled nitric oxide. J Appl Physiol 104 (2008) 925-930
3. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 (2005) 912-930
4. Travers J., Marsh S., Aldington S., Williams M., Shirtcliffe P., Pritchard A., et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 176 (2007) 238-242
5. Olin A.C., Bake B., and Torén K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 131 (2007) 1852-1856
6. Haight R.R., Gordon R.L., and Brooks S.M. The effects of age on exhaled breath nitric oxide levels. Lung 184 (2006) 113-119
7. Högman M., Lafih J., Meriläinen P., Bröms K., Malinovschi A., and Janson C. Extended NO analysis in a healthy subgroup of a random sample from a Swedish population. Clin Physiol Funct Imaging 29 (2009) 18-23
8. Shaw D.E., Berry M.A., Thomas M., Green R.H., Brightling C.E., Wardlaw A.J., et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 176 (2007) 231-237
9. Stick S., and Franklin P. NO more dogma: nitric oxide marker in asthma. Am J Respir Crit Care Med 179 (2009) 87-88
10. Taylor D.R. Exhaled nitric oxide: still alive, not laid to rest. Am J Respir Crit Care Med 179 (2009) 88-89
11. Michils A., Baldassarre S., and Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 31 (2008) 539-546
12. van Veen I.H., Sterk P.J., Schot R., Gauw S.A., Rabe K.F., and Bel E.H. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 27 (2006) 951-956
13. Gelb A.F., Taylor C.F., Nussbaum E., Gutierrez C., Schein A., Shinar C.M., et al. Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med 170 (2004) 737-741
14. Berry M., Hargadon B., Morgan A., Shelley M., Richter J., Shaw D., et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 25 (2005) 986-991
15. Lehtimäki L., Kankaanranta H., Saarelainen S., Turjanmaa V., and Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 18 (2001) 635-639
16. Brindicci C., Ito K., Barnes P.J., and Kharitonov S.A. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 131 (2007) 1353-1362
17. George S.C., Hogman M., Permutt S., and Silkoff P.E. Modeling pulmonary nitric oxide exchange. J Appl Physiol 96 (2004) 831-839
18. Verbanck S., Kerckx Y., Schuermans D., de Bisschop C., Guénard H., Naeije R., et al. The effect of posture-induced changes in peripheral nitric oxide uptake on exhaled nitric oxide. J Appl Physiol 106 (2009) 1494-1498
19. Battaglia S., den Hertog H., Timmers M.C., Lazeroms S.P., Vignola A.M., Rabe K.F., et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 60 (2005) 639-644
20. Global Initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO workshop report (2002), US Government Printing Office, Washington (DC) NHLBI pub no. 02-3659
21. Verbanck S., Schuermans D., Paiva M., and Vincken W. Nonreversible conductive airway ventilation heterogeneity in mild asthma. J Appl Physiol 94 (2003) 1380-1386
22. Verbanck S., Schuermans D., Noppen M., Van Muylem A., Paiva M., and Vincken W. Evidence of acinar airway involvement in asthma. Am J Respir Crit Care Med 159 (1999) 1545-1550
23. Downie S.R., Salome C.M., Verbanck S., Thompson B., Berend N., and King G.G. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 62 (2007) 684-689
24. Verbanck S., Schuermans D., Paiva M., and Vincken W. The functional benefit of anti-inflammatory aerosols in the lung periphery. J Allergy Clin Immunol 118 (2006) 340-346
25. Verbanck S., Schuermans D., Meysman M., Paiva M., and Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med 170 (2004) 414-419
26. Reddel H.K., Taylor D.R., Bateman E.D., Boulet L.P., Boushey H.A., Busse W.W., et al. American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 180 (2009) 59-99
27. Condorelli P., Shin H.W., Aledia A.S., Silkoff P.E., and George S.C. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol 102 (2007) 417-425
28. Kerckx Y., Michils A., and Van Muylem A. Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol 104 (2008) 918-924
29. Bush A. How early do airway inflammation and remodeling occur?. Allergol Int 57 (2008) 11-19
30. Menzies D., Nair A., Meldrum K.T., Fleming D., Barnes M., and Lipworth B.J. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 119 (2007) 328-335
31. Brindicci C., Ito K., Barnes P.J., and Kharitonov S.A. Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers. Chest 132 (2007) 581-588
32. Kharitonov S.A., Gonio F., Kelly C., Meah S., and Barnes P.J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 21 (2003) 433-438
33. Fritscher L.G., Rodrigues M.T., Zamel N., and Chapman K.R. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 103 (2009) 296-300
34. Cohen J., Douma W.R., ten Hacken N.H.T., Vonk J.M., Oudkerk M., and Postma D.S. Ciclesonide imporves measures of small airway involvement in asthma. Eur Respir J 31 (2008) 1213-1220
35. Suresh V., Shelley D.A., Shin H.W., and George S.C. Effect of heterogeneous ventilation and nitric oxide production on exhaled nitric oxide profiles. J Appl Physiol 104 (2008) 1743-1752
36. Verbanck S., and Paiva M. Model simulations of gas mixing and ventilation distribution in the human lung. J Appl Physiol 69 (1990) 2269-2279